GlassScriptPhysician profile
Lisa Lewis
NPI 1518118694
$4,608.59
in general payments reported to CMS, 2019-2025
18 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what 89% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $307 · 2022: $844 · 2023: $806 · 2024: $1,326 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,457.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $712.65 | 2021-2025 | Veltassa, Korsuva |
| Travere Therapeutics, INC. | $663.79 | 2022-2025 | Filspari |
| Otsuka America Pharmaceutical, INC. | $459.91 | 2021-2025 | Jynarque, Voyxact |
| Aurinia Pharma U.S., INC. | $439.86 | 2021-2025 | Lupkynis |
| Ardelyx, INC. | $424.18 | 2023-2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $337.51 | 2021-2025 | Gattex |
| Novartis Pharmaceuticals Corporation | $288.82 | 2023-2025 | |
| Akebia Therapeutics INC | $227.92 | 2021-2025 | Vafseo, Auryxia |
| Fresenius USA Marketing, INC. | $198.31 | 2021-2024 | Velphoro |
| Calliditas Therapeutics US INC. | $175.12 | 2024-2025 | Tarpeyo |
| Astrazeneca Pharmaceuticals LP | $140.97 | 2021-2023 | Farxiga, Lokelma |
| Amgen INC. | $122.60 | 2023-2024 | Parsabiv, Tavneos, Aranesp |
| Opko Pharmaceuticals, LLC | $121.98 | 2024-2025 | Rayaldee |
| Glaxosmithkline, LLC. | $106.28 | 2022-2023 | Benlysta, Jesduvroq |
| Renalytix Ai, INC. | $68.25 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $66.62 | 2023-2024 | |
| Lilly USA, LLC | $30.61 | 2024 | Jardiance |
| Fresenius USA Manufacturing, INC. | $23.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.